GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following is a reconciliation of goodwill by segment.

(in millions)	Medical Products and Therapies		Healthcare Systems and Technologies		Pharmaceuticals		Kidney Care		Total
Balance as of December 31, 2023	$	1,241	$	3,989	$	563	$	721	$	6,514
Impairment	—		—		—		(430)		(430)
Currency translation	(37)		(8)		(16)		(22)		(83)
Balance as of June 30, 2024	$	1,204	$	3,981	$	547	$	269	$	6,001

Other Intangible Assets, Net

The following is a summary of our other intangible assets.

									Indefinite-lived intangible assets
(in millions)	Customer relationships		Developed technology, including patents		Trade names		Other amortized intangible assets		Trade names		In process Research and Development		Total
June 30, 2024
Gross other intangible assets	$	3,442	$	3,806	$	1,097	$	118	$	680	$	157	$	9,300
Accumulated amortization	(802)		(2,451)		(206)		(100)		—		—		(3,559)
Other intangible assets, net	$	2,640	$	1,355	$	891	$	18	$	680	$	157	$	5,741
December 31, 2023
Gross other intangible assets	$	3,446	$	3,823	$	1,106	$	120	$	680	$	157	$	9,332
Accumulated amortization	(689)		(2,285)		(180)		(99)		—		—		(3,253)
Other intangible assets, net	$	2,757	$	1,538	$	926	$	21	$	680	$	157	$	6,079